Abstract:Objective To explore the VEGF,Flt-1 and KDR mRNA and protein expression in primary gallbladder carcinoma (PGC) and their correlation with primary gallbladder carcinoma clinicopathological characteristics.Methods The VEGF,Flt-1 and KDR mRNA and protein expression in the fresh resected samples of 21 cases of primary gallbladder carcinoma and 10 cases of gallbladder adenomaous ployps (GAP) was deteched by RT-PCR and immunohistochemistry.The correlation between VEGF,Flt-1 and KDR protein positive expression in PGC and the clinicopathological characteristics of PGC was analysed as well.Results The VEGF mRNA positive expression rates in all PGC and GAP cases were 90.47% (19/21) and 20% (2/10),the Flt-1 mRNA positive expression rates were 71.42% (15/21) and 0 (0/10) and the KDR mRNA positive expression rates were 85.71% (18/21) and 10% (1/10),respectively,with the difference being significant between PGC cases and GAP cases (P 0.05).The VEGF protein positive expression rates of all PGC and GAP cases were 80.95% (17/21) and 20% (2/10),the Flt-1 protein positive expression rates were 60.90% (13/21) and 10% (1/10) and the KDR protein positive expression rates were 76.19% (16/21) and 10% (1/10),respectively,with the difference being significant between two groups (P 0.05).The VEGF,Flt-1 and KDR protein positive expression rates in PGC cases with liver infiltration,lymphatic metastasis and Nevin IV and V stages were significantly higher than those in the cases withou liver infiltration,lymphatic metastasis and Nevin I,Ⅱ and Ⅲ stages of PGC (P 0.05).However,the positive expression rates of VEGF,Flt-1[BG)W][LM][BG(][BHDWG8*2,WK42ZQ0W] and KDR protein had no difference among the high,middle and low differentiation of PGC cases (P 0.05).Conclusion The VEGF,Flt-1 and KDR mRNA and protein were all overexpressed in the cases of PGC and the overexpressions of VEGF,Flt-1 and KDR protein were significantly correlated with PGC liver infiltration,lymphatic metastasis and Nevin IV and V stages,but not with the PGC pathological differentiation.

EXPRESSION OF P33ing1b IN GALLBLADDER CARCINOMA

Expression of P33ing1 in Colorectal Carcinomas and Its Clinical Significance

Study on the Expression of P33~(ING1) in Colorectal Carcinoma

VEGF, Flt-1 and KDR Mrna and Protein Expression in Primary Gallbladder Carcinoma and Their Correlation with Primary Gallbladder Carcinoma Clinicopathological Characteristics

The expression level of p33ING1 in gastric cancer and its clinical significance

Genetic Alterations and Reduced Expression of Tumor Suppressor P33^ing1b in Human Exocrine Pancreatic Carcinoma

Genetic Alteration and Reduced Expression of Tumor Suppressor P33~(ing1b) in Human Exocrine Pancreatic Carcinoma

Influence of Tumor Suppressor Gene P33ing1b on Growth of Pancreatic Carcinoma Cell Line SW1990

[P33(ing1) Gene Expression and Mutation in Stomach Cancer Tissues and Precarcinomatous Tissues].

Expression of pGSK-3α/β (Tyr279/216) and XIAP proteins in cholangiocarcinoma and their clinical significance

Relationship of vascular endothelial growth factor and p~(33ING1) with biological behaviors of gastric carcinoma

Epigenetic and genetic alterations of p33ING1b in ovarian cancer.

Expression and Clinical Significance of CyclinE,P27 in Primary Gallbladder Carci Noma

Expression and Significance of P53 and Bcl-2 Protein Pancreatic Adenocarcinoma

Expression and Clinical Significance of Chitinase-3-1ike Protein 1 in Gallbladder Cancer

Pathological significance of the expression of pituitary tumor transforming gene (PTTG) in gallbladder cancer tissues

Adenovirus-mediated Expression of P33 ING1b Induces Apoptosis and Inhibits Proliferation in Gastric Adenocarcinoma Cells in Vitro

Expression and Clinical Significance of P27 , CyclinD1 and CyclinE in the Primary Gallbladder Carcinoma

A Study on the Expressions of P21waf1 and P53 Protein in Cholangiocarcinoma

Expression of vascular endothelial growth factor and p33ING1 in breast carcinoma and significance

Expression of insulin-like growth factor-binding protein-2 (IGFBP2) and matrix metalloproteinase-9 (MMP9) and its clinicopathologieal significances in benign and malignant lesions of gallbladder